Mohite Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 2:03 am

Competitors of Mohite Industries Ltd

All Competitor Stocks of Mohite Industries Ltd

Quarterly Result

Last Updated: August 19, 2025, 1:00 pm

Below is a detailed analysis of the quarterly data for Mohite Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 25.37 Cr.. The value appears to be declining and may need further review. It has decreased from 35.06 Cr. (Mar 2025) to 25.37 Cr., marking a decrease of 9.69 Cr..
• For Expenses, as of Jun 2025, the value is 23.40 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 31.74 Cr. (Mar 2025) to 23.40 Cr., marking a decrease of 8.34 Cr..
• For Operating Profit, as of Jun 2025, the value is 1.97 Cr.. The value appears to be declining and may need further review. It has decreased from 3.32 Cr. (Mar 2025) to 1.97 Cr., marking a decrease of 1.35 Cr..
• For OPM %, as of Jun 2025, the value is 7.77%. The value appears to be declining and may need further review. It has decreased from 9.47% (Mar 2025) to 7.77%, marking a decrease of 1.70%.
• For Other Income, as of Jun 2025, the value is 0.88 Cr.. The value appears to be declining and may need further review. It has decreased from 1.16 Cr. (Mar 2025) to 0.88 Cr., marking a decrease of 0.28 Cr..
• For Interest, as of Jun 2025, the value is 2.44 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.44 Cr. (Mar 2025) to 2.44 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 1.43 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.17 Cr. (Mar 2025) to 1.43 Cr., marking an increase of 0.26 Cr..
• For Profit before tax, as of Jun 2025, the value is -1.02 Cr.. The value appears to be declining and may need further review. It has decreased from -0.13 Cr. (Mar 2025) to -1.02 Cr., marking a decrease of 0.89 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 269.23% (Mar 2025) to 0.00%, marking a decrease of 269.23%.
• For Net Profit, as of Jun 2025, the value is -1.01 Cr.. The value appears to be declining and may need further review. It has decreased from -0.48 Cr. (Mar 2025) to -1.01 Cr., marking a decrease of 0.53 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.05. The value appears to be declining and may need further review. It has decreased from -0.02 (Mar 2025) to -0.05, marking a decrease of 0.03.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: September 18, 2025, 2:12 am

Growth

Last Updated: September 5, 2025, 3:51 pm

Balance Sheet

Last Updated: July 25, 2025, 1:00 pm

Below is a detailed analysis of the balance sheet data for Mohite Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 20.00 Cr..
• For Reserves, as of Mar 2025, the value is 94.00 Cr.. The value appears strong and on an upward trend. It has increased from 91.00 Cr. (Mar 2024) to 94.00 Cr., marking an increase of 3.00 Cr..
• For Borrowings, as of Mar 2025, the value is 107.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 135.00 Cr. (Mar 2024) to 107.00 Cr., marking a decrease of 28.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 36.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 22.00 Cr. (Mar 2024) to 36.00 Cr., marking an increase of 14.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 257.00 Cr.. The value appears to be improving (decreasing). It has decreased from 268.00 Cr. (Mar 2024) to 257.00 Cr., marking a decrease of 11.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 74.00 Cr.. The value appears to be declining and may need further review. It has decreased from 81.00 Cr. (Mar 2024) to 74.00 Cr., marking a decrease of 7.00 Cr..
• For CWIP, as of Mar 2025, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 30.00 Cr..
• For Investments, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 2.00 Cr., marking an increase of 2.00 Cr..
• For Other Assets, as of Mar 2025, the value is 151.00 Cr.. The value appears to be declining and may need further review. It has decreased from 157.00 Cr. (Mar 2024) to 151.00 Cr., marking a decrease of 6.00 Cr..
• For Total Assets, as of Mar 2025, the value is 257.00 Cr.. The value appears to be declining and may need further review. It has decreased from 268.00 Cr. (Mar 2024) to 257.00 Cr., marking a decrease of 11.00 Cr..

However, the Borrowings (107.00 Cr.) are higher than the Reserves (94.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Mohite Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 1.00, marking a decrease of 9.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 5. It has decreased from 1.17 (Mar 24) to 0.27, marking a decrease of 0.90.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 5. It has decreased from 1.17 (Mar 24) to 0.27, marking a decrease of 0.90.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 3. It has decreased from 4.90 (Mar 24) to 0.59, marking a decrease of 4.31.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 5.67. It has decreased from 59.50 (Mar 24) to 5.67, marking a decrease of 53.83.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 5.67. It has decreased from 59.50 (Mar 24) to 5.67, marking a decrease of 53.83.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 8.30. It has decreased from 62.19 (Mar 24) to 8.30, marking a decrease of 53.89.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 1.30. This value is below the healthy minimum of 2. It has decreased from 11.10 (Mar 24) to 1.30, marking a decrease of 9.80.
• For PBIT / Share (Rs.), as of Mar 25, the value is 0.96. This value is within the healthy range. It has decreased from 7.37 (Mar 24) to 0.96, marking a decrease of 6.41.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.28. This value is within the healthy range. It has decreased from 1.29 (Mar 24) to 0.28, marking a decrease of 1.01.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 2. It has decreased from 1.17 (Mar 24) to 0.26, marking a decrease of 0.91.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 2. It has decreased from 1.17 (Mar 24) to 0.26, marking a decrease of 0.91.
• For PBDIT Margin (%), as of Mar 25, the value is 15.68. This value is within the healthy range. It has decreased from 17.84 (Mar 24) to 15.68, marking a decrease of 2.16.
• For PBIT Margin (%), as of Mar 25, the value is 11.66. This value is within the healthy range. It has decreased from 11.84 (Mar 24) to 11.66, marking a decrease of 0.18.
• For PBT Margin (%), as of Mar 25, the value is 3.40. This value is below the healthy minimum of 10. It has increased from 2.07 (Mar 24) to 3.40, marking an increase of 1.33.
• For Net Profit Margin (%), as of Mar 25, the value is 3.19. This value is below the healthy minimum of 5. It has increased from 1.87 (Mar 24) to 3.19, marking an increase of 1.32.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.19. This value is below the healthy minimum of 8. It has increased from 1.87 (Mar 24) to 3.19, marking an increase of 1.32.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.67. This value is below the healthy minimum of 15. It has increased from 2.11 (Mar 24) to 4.67, marking an increase of 2.56.
• For Return on Capital Employeed (%), as of Mar 25, the value is 9.57. This value is below the healthy minimum of 10. It has increased from 6.88 (Mar 24) to 9.57, marking an increase of 2.69.
• For Return On Assets (%), as of Mar 25, the value is 2.07. This value is below the healthy minimum of 5. It has increased from 0.88 (Mar 24) to 2.07, marking an increase of 1.19.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.65. This value is within the healthy range. It has decreased from 0.86 (Mar 24) to 0.65, marking a decrease of 0.21.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.93. This value is within the healthy range. It has decreased from 1.21 (Mar 24) to 0.93, marking a decrease of 0.28.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.63. It has increased from 0.49 (Mar 24) to 0.63, marking an increase of 0.14.
• For Current Ratio (X), as of Mar 25, the value is 2.75. This value is within the healthy range. It has decreased from 3.07 (Mar 24) to 2.75, marking a decrease of 0.32.
• For Quick Ratio (X), as of Mar 25, the value is 1.87. This value is within the healthy range. It has decreased from 2.18 (Mar 24) to 1.87, marking a decrease of 0.31.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.15. This value is below the healthy minimum of 4. It has increased from 1.17 (Mar 24) to 2.15, marking an increase of 0.98.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.90. This value is below the healthy minimum of 3. It has increased from 1.83 (Mar 24) to 1.90, marking an increase of 0.07.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 3. It has increased from 1.19 (Mar 24) to 1.39, marking an increase of 0.20.
• For Enterprise Value (Cr.), as of Mar 25, the value is 214.62. It has increased from 211.35 (Mar 24) to 214.62, marking an increase of 3.27.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.29. This value is within the healthy range. It has decreased from 1.69 (Mar 24) to 1.29, marking a decrease of 0.40.
• For EV / EBITDA (X), as of Mar 25, the value is 8.20. This value is within the healthy range. It has decreased from 9.47 (Mar 24) to 8.20, marking a decrease of 1.27.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.58 (Mar 24) to 0.59, marking an increase of 0.01.
• For Price / BV (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.86, marking an increase of 0.21.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.58 (Mar 24) to 0.59, marking an increase of 0.01.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness